Theranosova zviždačica kaže da je bivša šefica Elizabeth Holmes 'gotovo nepoznatljiva' u novom dokumentarcu i tvrdi da su filmski stvaraoci bili u zabludi
Bivši Theranosov zaposlenik i zviždač, Tyler Shultz, komentirao je novi dokumentarac o Elizabeth Holmes, bivšoj izvršnoj direktorici nestale biotehnološke tvrtke Theranos. U filmu, Holmes se značajno promijenio, što je iznenadilo Shultza, koji ju je opisao kao nekoć samouvjerenu i zapovjedničku u visokim postavama. Napomenuo je da je verzija Holmesa predstavljena u dokumentarcu izgledala 'slomljena' i gotovo neprepoznatljiva u usporedbi s osobom koju je poznavao. Shultz je također tvrdio da je Holmes obmanuo filmske tvorce pokazujući drugačiji uređaj za testiranje krvi od onog s kojim je svakodnevno radio, koji je propao u provjerama kvalitete i doveo do pružanja netočnih informacija o pacijentima. Filmski dokumentarist, Nathan Fielder, proveo je 34 dana s Holmesom prije nego što je zatvorena zbog optužbi za prevaru vezane za Theranos.
Nathan Fielder and Lance Oppenheim’s documentary, You Can See Everything, has secured a historic submission for the upcoming Academy Awards, becoming the first documentary in recent memory to be entered for Best Picture. The three-hour film, distributed by A24, generated $15 million in its opening weekend across 855 theaters, marking the largest box office debut for a documentary in over twenty years. Industry analysts suggest the film is poised to challenge long-standing Oscar norms, particularly with its inclusion of Amanda Seyfried in the Best Supporting Actress category. The film documents the final 34 days of Elizabeth Holmes’ freedom before she began serving an 11-year prison sentence for fraud related to her defunct health tech company, Theranos. The Academy submission includes nominations for Best Picture, Best Documentary Feature, and Best Director for Fielder and Oppenheim. However, the most discussed entry is for Best Supporting Actress, honoring Seyfried for a dual role as herself and as Holmes. Seyfried previously portrayed Holmes in the Hulu miniseries The Dropout, a performance that earned her an Emmy Award for Outstanding Lead Actress in 2022. Her appearance in the new documentary was kept under strict secrecy until the film’s release, surprising audiences at sold-out screenings in major markets. In the film, Holmes states she had never watched The Dropout until Fielder encouraged her to view it. The trio watches the series together in a beach cottage in Del Mar, California, days before Holmes departs for prison. Critical reception has been overwhelmingly positive, with the film achieving a record-setting 99 on Metacritic and a 98 percent approval rating on Rotten Tomatoes. On Letterboxd, the film holds a 4.7 out of 5 average rating, while some reports cite a slightly higher 4.8. Its IMDB score stands at 9.4, which would make it the highest-rated film in the platform’s history if the number stabilizes. The film’s commercial success was notable given its limited release strategy. It opened on fewer than 900 screens, yet outperformed the widely promoted Melania documentary, which opened on twice as many screens but grossed only $7.1 million. Only the action film Street Fighter surpassed You Can See Everything at the domestic box office that weekend, earning $31 million across 3,575 screens. The documentary follows Fielder as he moves into Holmes’ residence in San Diego, capturing her daily life with her partner, Billy Evans, and their two children. Fielder, known for his work on Comedy Central’s Nathan for You and HBO’s The Rehearsal, serves as the primary interviewer. He attempts to discern the truth regarding Holmes’ actions, though the narrative eventually shifts into a complex, meta-fictional structure that critics have described as rewriting the rules of the documentary form. Holmes maintains her innocence throughout the film, denying any wrongdoing despite her 2022 conviction on four counts of fraud and conspiracy. She was found guilty of misleading investors about the capabilities of Theranos’ blood testing technology, which promised to run hundreds of diagnostic tests from a single finger prick. Reactions from figures associated with the original Theranos scandal have been mixed. Tyler Shultz, a former Theranos intern and key whistleblower whose testimony aided a Wall Street Journal investigation, stated he was "pretty shocked" by the portrayal of Holmes in the film. Shultz noted that the woman on screen appeared "almost unrecognizable" compared to the confident leader he knew, describing her instead as looking like a "broken woman." He further alleged that Holmes misled the filmmakers by displaying a specific blood-testing device during interviews. Shultz argued that the device shown was not the one used to deceive regulators or provide patients with incorrect medical results, claiming Holmes steered Fielder down a "completely different rabbit hole." Legal proceedings against Holmes concluded with her conviction in 2022. She was sentenced to 11 years in prison and ordered to pay hundreds of millions of dollars in restitution alongside former executive Ramesh Balwani. Her sentence was recently reduced by 12 months by a federal judge in March, citing updated sentencing guidelines for non-violent first-time offenders. Holmes is currently incarcerated at Federal Prison Camp Bryan in Texas. Reports indicate she has been approved for transfer to the Austin Transitional Center, a halfway house near Austin, where she is scheduled to begin serving the remainder of her sentence next August. She has also petitioned President Donald Trump for clemency. The film’s release has reignited public interest in the broader implications of the Theranos case for the scientific community. While the documentary focuses on Holmes’ personal journey, it has brought renewed attention to legitimate blood-testing startups operating in the industry’s shadow. The narrative arc contrasts the initial hype surrounding Holmes, who was once celebrated as a female Steve Jobs after founding Theranos at age 19, with the subsequent exposure of the fraud by journalist John Carreyrou. As A24 prepares to expand the film’s theatrical run to capitalize on strong word-of-mouth, the studio expects continued strong performance in its second week. The combination of critical acclaim, cultural curiosity, and the unique nature of the subject matter has positioned the film as a standout title for the current awards season.
Idi na primarne izvore (2)
Službeni izvori na kojima se izvještavanje temelji. Pročitaj ih izravno da zaobiđeš uokvirivanje.
Dokumentarni film pod nazivom 'Možeš vidjeti sve', u režiji Nathana Fieldera, usredotočen je na Elizabeth Holmes, bivšu izvršnu direktoricu Theranosa, biotehnološke tvrtke uključene u veliki skandal s prijevarom. Film je dobio široko priznanje kritičara i trebao bi biti nominiran za više kategorija Oscara, uključujući najbolji film, najbolji dokumentarac i najbolju režiju. Amanda Seyfried, koja je prethodno glumila Holmesa u seriji Hulu 'The Dropout', ima dvostruku ulogu u dokumentarcu, prikazujući i sebe i Holmesa. Film je postigao visoke ocjene na platformama recenzija poput Metacritic i IMDb i imao je uspješnu debitu na blagajni unatoč ograničenoj kazališnoj distribuciji.
Procjena pristranosti (Sredina): U članku se govori o dokumentarcu o slučaju korporativne prijevare koji uključuje Elizabeth Holmes i Theranos. Iako je tema uključuje visokog profila pravno i etičko pitanje, članak se prvenstveno usredotočuje na film kritički prijem, nagrade potencijal, i box office uspjeh. Ne postoji otvorena politika
Zašto činjenice (85): The article accurately reports the film's critical reception, its potential Oscar submissions, and Amanda Seyfried's dual role. However, it omits some details from the primary source such as the specific dates of the film's release and the exact nature of the film's structure (e.g., the 34 days befo
Zašto objektivnost (65): The article uses emotionally charged language such as 'explosive new documentary' and 'almost unrecognizable' when describing Elizabeth Holmes. It frames the film as 'hotly anticipated' and emphasizes the shock factor of the portrayal, which introduces a subjective interpretation rather than present
Bivši Theranosov zaposlenik i zviždač, Tyler Shultz, komentirao je novi dokumentarac o Elizabeth Holmes, bivšoj izvršnoj direktorici nestale biotehnološke tvrtke Theranos. U filmu, Holmes se značajno promijenio, što je iznenadilo Shultza, koji ju je opisao kao nekoć samouvjerenu i zapovjedničku u visokim postavama. Napomenuo je da je verzija Holmesa predstavljena u dokumentarcu izgledala 'slomljena' i gotovo neprepoznatljiva u usporedbi s osobom koju je poznavao. Shultz je također tvrdio da je Holmes obmanuo filmske tvorce pokazujući drugačiji uređaj za testiranje krvi od onog s kojim je svakodnevno radio, koji je propao u provjerama kvalitete i doveo do pružanja netočnih informacija o pacijentima. Filmski dokumentarist, Nathan Fielder, proveo je 34 dana s Holmesom prije nego što je zatvorena zbog optužbi za prevaru vezane za Theranos.
Procjena pristranosti (Sredina): U članku su predstavljene perspektive zviždača i uključeni su izravni citati od njega, nudeći uravnotežen pogled na njegova promatranja u vezi s portretiranjem Elizabeth Holmes u dokumentarcu i njegovim tvrdnjama o tome da je ona zavarala filmske tvorce. Nema očigledne pristranosti prema bilo kojoj strani, i to
Zašto činjenice (70): The article provides some accurate information about the film and Elizabeth Holmes but includes speculative statements about the filmmakers being 'misled.' It references Tyler Shultz's comments but omits key contextual details from the primary source, such as the film's eligibility for various award
Zašto objektivnost (50): The article exhibits a strong bias towards Tyler Shultz's perspective, using phrases like 'explosive new documentary' and emphasizing the contrast between the on-screen portrayal of Holmes and the whistleblower's personal experience. The tone is highly opinionated and presents Shultz's viewpoint as
Nature NewsNeovisanSredinaČinjenice: nije otkriven službeni izvor/dokumentObjektivnost 100
Izdanje filma 'Možeš sve vidjeti' obnovilo je javno zanimanje za testiranje krvi, koji nastavljaju djelovati unatoč dugotrajnom utjecaju skandala Theranos. U članku se navodi da te tvrtke ustraju u razvoju dijagnostičkih tehnologija dok se nose s izazovima ugleda povezanim s Elizabeth Holmes i njenim bivšim poduhvatom. Ovakvo oživljavanje ponovno stavlja široko područje medicinske dijagnostike u središte pažnje, istaknuvši potencijal novih inovacija i skepticizam koji ih okružuje.
Procjena pristranosti (Sredina): Predmet se odnosi na znanstvene inovacije i povijest tvrtki u zdravstvenom sektoru, koji je u velikoj mjeri apolitičan. Iako bi se pominjanje propusta u regulatornim propisima moglo dotaknuti politike, ovdje se fokusira na trenutačno stanje industrije i percepciju javnosti, a ne na strankarsku raspravu ili političku analizu.
Zašto činjenice: nije otkriven službeni izvor/dokument
Zašto objektivnost (100): The tone is neutral and journalistic. While 'enthralls' is slightly positive, it aligns with the objective data of high ratings provided in the source. There is no heavy-handed editorializing or bias.
Kako je izvijestila svaka strana
Isti događaj, grupiran prema političkom nagibu medija koji su o njemu izvještavali.
progresivno
sredina
konzervativno
★
Kako je izvijestila svaka strana
Podržite neovisne vijesti svjesne pristranosti i otključajte društveni puls, glasovanje zajednice i sve ostale značajke za podupiratelje.